Absci Balance Sheet Health
Financial Health criteria checks 5/6
Absci has a total shareholder equity of $221.5M and total debt of $6.2M, which brings its debt-to-equity ratio to 2.8%. Its total assets and total liabilities are $255.5M and $34.0M respectively.
Key information
2.8%
Debt to equity ratio
US$6.25m
Debt
| Interest coverage ratio | n/a |
| Cash | US$145.25m |
| Equity | US$221.49m |
| Total liabilities | US$34.04m |
| Total assets | US$255.53m |
Recent financial health updates
Recent updates
Absci: Embryonic Pipeline Looks Expensive Relative To Peers
Oct 29Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile
Oct 03Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships
Jul 28Is Absci (NASDAQ:ABSI) A Risky Investment?
Jun 17
Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula
May 16Absci: Differentiated Antibody Discovery Play
Feb 27Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M
Aug 11Absci teams up to help develop antibody drugs for cancer
Jul 07Merck And Absci: AI-Driven Drug Development Deal Has Promise, But May Take Years To Pay Out
Jan 10IPO Day With Absci CEO Sean McClain - The Google Of Synthetic Biology (Video)
Jul 22Financial Position Analysis
Short Term Liabilities: ABSI's short term assets ($165.2M) exceed its short term liabilities ($25.5M).
Long Term Liabilities: ABSI's short term assets ($165.2M) exceed its long term liabilities ($8.6M).
Debt to Equity History and Analysis
Debt Level: ABSI has more cash than its total debt.
Reducing Debt: Insufficient data to determine if ABSI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ABSI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ABSI has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 17.2% each year.